Results 151 to 160 of about 13,638 (219)

Correction: Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphoma. [PDF]

J Immunother Cancer
europepmc   +1 more source

Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation. [PDF]

Front Immunol
Xianshu K, Zhonghua L, Junyu D, Qing P, Li Z, Feiyue Z, Xuqing S.   +6 more
europepmc   +1 more source

Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation. [PDF]

Front Immunol
Kang X, Yang X, Wu H, Tong X, Wang S.
europepmc   +1 more source

Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma. [PDF]

J Clin Oncol
Vile RG.
europepmc   +1 more source

Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy. [PDF]

Exp Hematol Oncol
Morales-Molina A, Franco-Luzón L, Garcia-Rodriguez P, González-Murillo A, García-Castro J, Ramírez M.   +5 more
europepmc   +1 more source

Bibliometric evaluation of research trends and hotspots concerning the interaction between immune checkpoint inhibitors and glioma. [PDF]

Discov Oncol
Xu D, He L, Zhao X, Yang Z.
europepmc   +1 more source

Polio virotherapy provokes MDA5 signaling and CD4⁺ T cell help to mediate cancer <i>in situ</i> vaccination. [PDF]

Microbiol Mol Biol Rev
Gromeier M, Brown MC.
europepmc   +1 more source

Alphavirus replicons encoding IFN-γ enhance cancer virotherapy by overcoming macrophage-mediated suppression. [PDF]

iScience
Horvathova L, Kinderman P, Janzen T, Hoogeboom BN, Weissing FJ, van Montfoort N, Daemen T, Bhatt DK.   +7 more
europepmc   +1 more source

Heat up and Destroy: Immunotherapy of "Cold" Tumors Using the Example of Glioblastoma. [PDF]

Int J Mol Sci
Nikitina Y, Kazakova A, Bogachek M, Leonteva A, Vasileva N, Sergeevichev D, Vladimirov S, Richter V, Nushtaeva A.   +8 more
europepmc   +1 more source

Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential. [PDF]

Front Microbiol
Gupta A, Chavan SR, Gadepalli R, Pareek P.   +3 more
europepmc   +1 more source